Related references
Note: Only part of the references are listed.Exploratory assessment of dose proportionality: review of current approaches and proposal for a practical criterion
Juergen Hummel et al.
PHARMACEUTICAL STATISTICS (2009)
Detection of novel reactive metabolites of trazodone:: Evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine
Bo Wen et al.
DRUG METABOLISM AND DISPOSITION (2008)
A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder
Andrew A. Nierenberg et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2008)
Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients
GM Saletu-Zyhlarz et al.
NEUROPSYCHOBIOLOGY (2003)
Divisability of diltiazem matrix sustained-release tablets
P Costa et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2001)
Confidence interval criteria for assessment of dose proportionality
BP Smith et al.
PHARMACEUTICAL RESEARCH (2000)
Share Paper
